Position in AQST
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$89,028
-$40,041 QoQ
Shares Held
21,401
-31.2% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#105
of 185 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AQST Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PFG Investments, LLC holds $2,064,521 across 8 Drug Manufacturers - Specialty & Generic names. AQST ranks #7 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
20,043 | $679,056 | |
| 2 | PRGO |
PERRIGO Co plc
|
30,050 | $312,219 | |
| 3 | ZTS |
Zoetis Inc.
|
3,856 | $277,092 | |
| 4 | VTRS |
Viatris Inc
|
17,391 | $276,169 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
375 | $203,186 | |
| 6 | HLN |
Haleon plc
|
18,560 | $173,164 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
This page
|
21,401 | $89,028 | |
| 8 | TLRY |
Tilray Brands, Inc.
|
12,162 | $54,607 |
All Filings in AQST
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $89,028 | 21,401 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $129,069 | 31,101 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $224,814 | 34,801 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $216,338 | 38,701 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $154,580 | 46,701 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $132,532 | 45,701 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $173,372 | 48,700 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $240,036 | 48,200 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $153,400 | 59,000 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $204,480 | 48,000 | Shares | Sole | 2024-04-22 | |
| No filing history on record for this holder in this stock. | ||||||